Results 81 to 90 of about 646,053 (288)

WHAT YOU SHOULD KNOW ABOUT HOG CHOLERA [PDF]

, 1959
I. WHAT IS HOG CHOLERA? Hog cholera is a deadly, contagious disease that attacks swine only. The disease is caused by hog cholera virus, an agent so small (1/250,000 of an inch) that it can even pass through a fine porcelain filter.
Aitken, W.A., Gifford, C.W., Hendershott, R.A., Hutchings, L.M., McNutt, S.H., Quin, A.H., Ray, J.D., Shope, R.E.   +7 more
core   +1 more source

Adults aged 65 years and older in South Africa have a responsibility to vaccinate against influenza

Developing World Bioethics, EarlyView.
Abstract In this article, we draw on the thinking about incompleteness and conviviality grounded in Afro‐communitarianism ethics from the Global South to argue that adults aged 65 years and above have a prima facie responsibility to vaccinate against influenza.
Ruach Sarangarajan, Cornelius Ewuoso
wiley   +1 more source

Use of Vibrio cholerae Vaccine in an Outbreak in Guinea [PDF]

, 2014
Producción CientíficaThe use of vaccines to prevent and control cholera is currently under debate. Shanchol is one of the two oral cholera vaccines prequalified by the World Health Organization; however, its effectiveness under field conditions and the ...
Ciglenecki, Iza, Diallo, Alpha Amadou, Eiros Bouza, José María, Grais, Rebecca F., Grout, Lise, Heile, Melat, Itama, Christian, Legros, Dominique, Luquero Alcalde, Francisco Javier, Mengel, Martin A., Page, Anne-Laure, Quilici, Marie-Laure, Sakoba, Keita, Serafini, Micaela, Traore, Bala   +14 more
core   +3 more sources

Use of Oral Cholera Vaccines in an Outbreak in Vietnam: A Case Control Study

PLoS Neglected Tropical Diseases, 2011
Background Killed oral cholera vaccines (OCVs) are available but not used routinely for cholera control except in Vietnam, which produces its own vaccine.
D. Anh, A. Lopez, V. Thiem, S. Grahek, T. Duong, Jin Kyung Park, Hye Jung Kwon, M. Favorov, N. T. Hien, J. Clemens   +9 more
semanticscholar   +1 more source

What in the world is global health? A conceptual analysis

Developing World Bioethics, EarlyView.
Abstract This article suggests that the concept of global health – and to an extent the field that it designates ‐ is problematic in various ways. Within public health, the concept of the ‘public’ has been widely investigated. However, “global health” has been introduced in academic, policy, and public discussion with comparably lower level of ...
Alberto Giubilini
wiley   +1 more source

Design, synthesis and determination of physical and chemical characteristics of glycoconjugates as model for oligosaccharide vaccines against vibrio cholerae [PDF]

Makedonsko Farmacevtski Bilten, 2003
Cholera is toxin-mediated enteroinfection, with epidemic character and there are approximately 120000 death cases per year worldwide. Protection against cholera has not been accomplished due to deficiencies in the licensed vaccines.
Aleksandra Grozdanova, Ana Poceva, Katerina Milenkova, Ljubica Suturkova   +3 more
doaj  

Tackling Cholera Outbreak Amidst COVID-19 Pandemic in Nigeria: Challenges and Recommendations

Public Health Reviews, 2022
Background: Since the first confirmed case of the Novel Coronavirus Disease 2019 (COVID-19) in Nigeria, the pandemic has become a major public health challenge, affecting different sectors of the country.
Alhaji Umar Sow, Usman Abubakar Haruna, Usman Abubakar Haruna, Oladunni Abimbola Amos, Oladunni Abimbola Amos, Edward Olorunfemi Olajide, Terhemen Amene, Oluwatomisin Dara Odususi, Bukola Adedoyin Adewusi, Chinedu Abia, Jackson Safari, Florence Wuraola Sorinola, Hassan Olayemi Alaka, Sulaiman Muhammad Musa   +13 more
doaj   +1 more source

Flagellins as Vaccine Adjuvants and Cancer Immunotherapy: Recent Advances and Future Prospects

Immunology, EarlyView.
The figure depicts the role of flagellin in immune cells. Flagellin interacts with TLR5, resulting in the formation of homodimers and the recruitment of MyD88, which activates the IκB and MAPK signalling pathways. This results in the activation of NF‐κB and AP‐1, producing TNF‐α, IL‐6, IL‐8, and IL‐12.
Asma Talukder, Md. Mijanur Rahman, Md. Sifat Rahi, Dean L. Pountney, Ming Q. Wei   +4 more
wiley   +1 more source

An Opportunity Not To Be Missed: Vaccination as an Entry Point for Hygiene Promotion and Diarrhoeal Disease Reduction in Nepal [PDF]

, 2013
This report aims to ascertain whether or not vaccination programmes offer a useful entry point for hygiene promotion and to define options for piloting and scaling up of a hygiene promotion intervention in ...
Katie Greenland, Om Gautam, Yael Velleman   +2 more
core  

Vaccines against toxoplasma gondii : challenges and opportunities [PDF]

, 2009
Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the lack of effective drugs with few adverse effects.
Aliberti J, Angus CW, Aosai F, Aosai F, Awan KJ, Beghetto E, Bommireddy R, Bonenfant C, Boyle JP, Brinkmann V, Buxton D, Bülow R, Caetano BC, Conacher M, Cong H, Cong H, Constant SL, Couper KN, Craig W Roberts, Cui YL, Cuppari AF, Curtsinger JM, Curtsinger JM, Cutchins EC, Darcy F, Dautu G, Debard N, Debierre-Grockiego F, DeGregorio E, Denkers EY, Desolme B, Duquesne V, Echeverria PC, Elisabeth Förster-Waldl, Erik Jongert, Escajadillo A, Eskild Petersen, Fachado A, Fachado A, Flori P, Fox B, Frenkel JK, Garcia JL, Garcia JL, Gatkowska J, Gazzinelli R, Gazzinelli RT, Golkar M, Hakim FT, Igarashi M, Innes EA, Ishii K, Ishii KJ, Ismael AB, Ismael AB, Johnson LL, Jongert E, Jongert E, Jongert E, Kasper LH, Khan IA, Kijlstra A, Kodjikian L, Krahenbuhl JL, Kringel H, Letscher-Bru V, Letscher-Bru V, Leyva R, Lindsay DS, Liu Q, Lourenco EV, Lourenço EV, Martin V, McLeod R, Mishima M, Mishima M, Mohamed RM, Mévélec MN, Mévélec MN, Nicola Gargano, Nielsen HV, Nielsen HV, Petersen E, Petrovsky N, Pettersen EK, Pfefferkorn ER, Qu D, Reikvam A, Roque-Resendiz JL, Sabin AB, Sayles PC, Schaap D, Scorza T, Siachoque H, Sibley LD, Silveira C, Stanley AC, Stockinger B, Supply P, Taneja V, Vandepapelierea P, Velge-Roussel F, Velge-Roussel F, Vercammen M, Vogel N, Vyas JM, Waldeland H, Wang H, Wilkins MF, Williams MA, Xue M, Xue M, Yang CD, Yarovinsky F, Zenner L, Zhang G, Zhang J, Zimmermann S   +117 more
core   +3 more sources